1,208 results on '"Horneff Gerd"'
Search Results
2. Verlauf der COVID-19-Pandemie bei pädiatrisch-rheumatologischen Patienten in Deutschland über die ersten 3 Jahre (2020 bis 2022)
3. Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort
4. Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study
5. Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022
6. Treatment of non-systemic juvenile idiopathic arthritis
7. No benefit of the combination therapy etanercept and methotrexate compared to etanercept mono therapy in juvenile idiopathic arthritis – a matched pair analysis
8. German evidence- and consensus-based guidelines 2011 for the treatment of juvenile idiopathic arthritis (JIA)
9. Analgesia for joint punctures in children - experiences with a nitrous oxide / oxygen mixture (LIVOPAN®)
10. Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients—analysis of the BiKeR registry
11. Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis
12. A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.
13. Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review
14. Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort
15. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
16. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
17. Polyartikuläre Verlaufsformen der juvenilen idiopathischen Arthritis
18. Zytokin-Inhibitoren in der pädiatrischen Rheumatologie
19. Zytokine in der pädiatrischen Rheumatologie
20. Long‐Term Maintenance of Clinical Responses by Individual Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Abatacept
21. Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis.
22. Autoinflammation – Eine klinische und genetische Herausforderung
23. Spondyloarthritiden im Kindes- und Erwachsenenalter
24. 5/w mit Gelenkschmerzen: Vorbereitung auf die Facharztprüfung: Fall 41
25. A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
26. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
27. Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study
28. Outcome of adult patients with JIA treated with the biosimilar Benepali®: results of the biologic register JuMBO
29. Autoinflammation – Eine klinische und genetische Herausforderung
30. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
31. Zytokine in der pädiatrischen Rheumatologie
32. Zytokin-Inhibitoren in der pädiatrischen Rheumatologie
33. Polyartikuläre Verlaufsformen der juvenilen idiopathischen Arthritis
34. Episodische Fiebersyndrome – autoinflammatorische Syndrome
35. Juvenile idiopathische Arthritis
36. Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis.
37. Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever.
38. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort
39. Vergleich der Therapie mit JAK-Inhibitoren bei der juvenilen idiopathischen Arthritis in der klinischen Praxis und in den Zulassungsstudien
40. Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry
41. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
42. Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
43. S2k guideline: Diagnosis and therapy of localized scleroderma
44. Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
45. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry
46. Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
47. Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry
48. Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
49. Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
50. Zytokine in der pädiatrischen Rheumatologie
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.